Bi-Cheng Liu Selected Research

Doxorubicin (Adriamycin)

1/2020	Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury.
1/2020	Rab27a dependent exosome releasing participated in albumin handling as a coordinated approach to lysosome in kidney disease.
1/2019	Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bi-Cheng Liu Research Topics

Disease

33	Fibrosis (Cirrhosis) 05/2024 - 11/2006
27	Chronic Renal Insufficiency 03/2024 - 01/2006
21	Kidney Diseases (Kidney Disease) 03/2024 - 01/2013
21	Inflammation (Inflammations) 03/2024 - 08/2013
12	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 01/2007
11	Hypoxia (Hypoxemia) 01/2023 - 12/2018
11	Diabetic Nephropathies (Diabetic Nephropathy) 03/2022 - 04/2004
11	Proteinuria 01/2021 - 01/2003
7	Hypertension (High Blood Pressure) 05/2024 - 11/2004
6	Anemia 11/2020 - 12/2018
6	Hypertrophy 03/2016 - 01/2003
5	Neoplasms (Cancer) 01/2024 - 01/2020
5	Renal Insufficiency (Renal Failure) 01/2021 - 01/2006
4	Wounds and Injuries (Trauma) 04/2024 - 04/2013
4	Ischemia 02/2024 - 01/2018
4	Chronic Kidney Failure (Chronic Renal Failure) 03/2022 - 01/2014
4	Secondary Hyperparathyroidism 07/2019 - 01/2017
4	Albuminuria 01/2019 - 03/2011
3	Ureteral Obstruction 03/2024 - 01/2021
3	Hyperkalemia 02/2023 - 12/2019
3	Infections 01/2023 - 10/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2021 - 03/2016
3	IGA Glomerulonephritis (IGA Nephropathy) 06/2021 - 01/2018
3	Hyperplasia 09/2020 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 01/2018
2	Genomic Instability 01/2024 - 01/2022
2	Atrophy 10/2022 - 12/2014
2	Reperfusion Injury 05/2022 - 01/2018
2	Vascular Calcification 05/2021 - 11/2016
2	Sclerosis 01/2021 - 01/2020
2	Diabetic Cardiomyopathies 03/2016 - 01/2013
1	Disease Progression 04/2024
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2024

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 08/2023 - 07/2010
13	Messenger RNA (mRNA)IBA 03/2022 - 01/2011
10	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2003
10	CreatinineIBA 03/2022 - 01/2003
8	Angiotensin IIIBA 05/2024 - 11/2003
8	AlbuminsIBA 11/2022 - 01/2003
6	Connective Tissue Growth FactorIBA 03/2013 - 11/2003
5	Parathyroid Hormone (Parathormone)IBA 06/2021 - 01/2014
5	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2013
5	InflammasomesIBA 07/2020 - 12/2014
5	Cinacalcet (Sensipar)FDA Link 07/2019 - 01/2014
4	CytokinesIBA 03/2024 - 01/2006
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2018
4	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2022 - 12/2019
4	roxadustatIBA 05/2022 - 12/2019
4	Adenine FDA LinkGeneric 01/2019 - 01/2014
4	Angiotensin Receptor AntagonistsIBA 01/2013 - 03/2011
3	VimentinIBA 05/2024 - 09/2015
3	LipidsIBA 04/2024 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2021
3	fibroblast growth factor 21IBA 01/2023 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 01/2006
3	Oxygen (Dioxygen)IBA 03/2022 - 12/2018
3	ChemokinesIBA 01/2022 - 01/2021
3	Prolyl-Hydroxylase InhibitorsIBA 11/2020 - 11/2019
3	IronIBA 03/2020 - 12/2019
3	Hemoglobins (Hemoglobin)IBA 03/2020 - 01/2008
3	Uric Acid (Urate)IBA 01/2020 - 01/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2019
3	NitrogenIBA 09/2015 - 01/2008
3	Urea (Carbamide)FDA LinkGeneric 09/2015 - 01/2008
3	Irbesartan FDA LinkGeneric 03/2012 - 04/2004
2	integrin-linked kinaseIBA 03/2024 - 07/2007
2	PotassiumIBA 02/2023 - 12/2019
2	GlucocorticoidsIBA 01/2023 - 01/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2019
2	Protein Isoforms (Isoforms)IBA 11/2022 - 02/2022
2	SodiumIBA 09/2022 - 03/2016
2	Therapeutic UsesIBA 05/2022 - 08/2013
2	Phosphorus (Red Phosphorus)IBA 01/2022 - 01/2018
2	LigandsIBA 01/2022 - 01/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 09/2010
2	Peptides (Polypeptides)IBA 10/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 06/2021 - 12/2015
2	HematinicsIBA 11/2020 - 03/2020
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2019
2	Erythropoietin FDA Link 12/2019 - 12/2018
2	CollagenIBA 01/2019 - 04/2013
2	MineralsIBA 01/2019 - 01/2018
2	Fibronectins (Fibronectin)IBA 02/2018 - 03/2013
2	CalciumIBA 01/2018 - 03/2016
2	Triglycerides (Triacylglycerol)IBA 12/2014 - 01/2008
2	pirfenidoneIBA 03/2013 - 01/2013
1	AntigensIBA 05/2024
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2024
1	Phosphotransferases (Kinase)IBA 03/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2024
1	LipopolysaccharidesIBA 03/2024
1	FumaratesIBA 02/2024
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2024
1	Phospholipase A2 ReceptorsIBA 01/2024

Therapy/Procedure

14	Therapeutics 03/2023 - 01/2018
5	Renal Dialysis (Hemodialysis) 01/2023 - 01/2018
3	Nephrectomy 01/2020 - 08/2013
3	Hematopoietic Stem Cell Transplantation 11/2010 - 01/2007
2	Precision Medicine 12/2018 - 09/2017